The purpose of this review is to critically analyze the effectiveness of adhesive barriers in adhesion prevention in terms of incidence and extent of postoperative adhesions and to help one choose the best and the most cost-effective, among those available in market today.
trauma is the primary contributing factor. Infection, ischemic damage and exposure to foreign materials can significantly contribute to this.
2
Adhesions can be primary or de novo adhesions vs secon dary or reformed adhesions. The former are freshly formed ones, on locations devoid of adhesions before and the latter are those adhesions that undergo adhesiolysis and recur at the same location.
3 Adhesions may also be classified based on the location, as intraabdominal or intrauterine. Virtually, any surgical procedure performed transperitoneally can lead to adhesions ranging from minimal scarring of serosal surface to firm agglutination of structures. The formation of adhesions following an open approach in gynecology is more than a common entity. It has been reported that intraabdominal adhesions occur in 60 to 90% of women who have undergone major gynecological proce dures. 4, 5 Further, a recent study by 6 conducted in Scotland reported that women undergoing an initial open surgery for gynecological conditions had a 5% likelihood of being rehospitalized because of adhesions over the next 10 years. Though many adhesions resulting from gynecological surgery have little or no detrimental effect on patients, a consi derable proportion of them can result in serious short and longterm complications, including infertility, 7 pelvic pain 8 and intestinal obstruction, resulting in a reduced quality of life 9 often requiring readmission to hospital and additional more complicated surgical procedures and indeed increased surgical costs. 10 Propensity to form adhesions are thought to be patient specific. The nutritional status, disease entities like diabetes and the presence of concurrent infectious processes also contribute. They impair leukocyte and fibroblast function in these patients, potentially increasing adhesion formation. It has also been shown that postsurgical adhesions increase with the age of the patient, the number of previous surgeries and the type and complexity of surgical procedures.
11 When lysed, adhesions have a tremendous propensity to reform. Since, its first introduction in gynecological surgery in 1986, laparoscopy with its minimal access to the perito neal cavity has been claimed to be associated with reduced rates of adhesion formation 12 13 reported on data from 24,046 patients undergoing laparoscopy or laparotomy for gynecological conditions and partially contrasted with the results from the previous studies. Data from this study have supported the concept that laparoscopy is less adhesiogenic than laparotomy but this stands only with respect to laparos copic tubal sterilization procedures, which represented a considerable proportion of laparoscopies (59%), and the vast majority of those categorized as having 'lowrisk' of directly adhesionrelated readmission within the first year of surgery. However, for 'highrisk' (laparoscopic adhesiolysis and cyst drainage) and 'mediumrisk' (other interventions not otherwise categorized) laparoscopies, which constituted 40% of gynecological procedures, the risk of adhesion related readmission has been shown to be considerable (1 in 80 and 1 in 70 respectively) and substantially higher than for the conventional approach (1 in 170) . In the back ground of such controversies related to the occurrence of more or comparable or lesser incidence of adhesions in laparoscopy, this article specifically attempts to look at the realistic expectations from adhesion barriers in the field of gynecological laparoscopy.
Adhesion Barriers
It was quite a logical thought process of the initial days that mechanical separation of peritoneal surfaces of the pelvic organs during the early days of the healing postoperatively, is a way to prevent postoperative adhesions. Intraabdominal instillates and solid barriers were the options available. The ideal barrier should be noninflammatory, nonimmunogenic, persist during the remesothelialization, remain in place without suture, remain active in the presence of blood and be completely biodegradable.
MATERIAlS ANd METHOdS
A literature search was performed using Google, Yahoo, Springerlink and Highwire Press.
The following search terms were used: adhesion barriers, oxidized regenerated cellulose, Interceed, icodex trin, ADEPT, hyaluronic acid (HA), intergel/hyalobarrier, sepracoat, viscoelastic gel, oxiplex.
Though there are numerous adhesion barrier agents and devices available in market today (Table 1) , we decided to critically evaluate the evidence available about the most commonly used ones in the field of operative gynecology.
dISCUSSION

Oxidized regenerated Cellulose (Interceed)
The most relevant data related to this comes from a study conducted by Sekiba K (1992).
14 They evaluated
Interceed (TC7) in a randomized, multicenter clinical study. Sixtythree infertility patients had bilateral pelvic sidewall adhesions removed at laparotomy. One pelvic sidewall was covered by Interceed and the other was left uncovered. The deperitonealized areas (N = 205) of all sidewalls were divided into three groups: less than 100 mm 2 , N = 72; 100 1000 mm 2 , N = 95; and more than 1000 mm 2 , N = 38. The effectiveness of interceed was evaluated at laparoscopy 10 to 98 days after laparotomy. Significantly more adhesions were observed at laparoscopy on the control pelvic sidewalls (48 of 63, 76%) than on the treated sides (26 of 63, 41%) (p < 0.0001). The interceed treated sidewalls also had sig nificantly less area involved with adhesions at laparoscopy (p < 0.05, p < 0.001 and p < 0.001 in the three groups, respectively) ( Table 2 ). Twentyeight women with severe endometriosis also had significantly more adhesions on the control side (23 of 28, 82%) than on the treated side (14 of 28, 50%) (p < 0.05).
Icodextrin (AdEPT)
The best of the available evidence regarding this adhesion barrier comes from a study done in 2011 by Trew et al. 15 This randomized, doubleblind study comprising of 498 subjects was designed to assess the efficacy and safety of 4% icodextrin solution (ADEPT) in the reduction of de novo adhesion compared to lactated Ringer's solution (LRS) (Table 3) .
Hyaluronic Acid (Intergel)
The study which investigated the efficacy of this autocross linked barrier was done in 2006 by Mais et al. 16 Fiftytwo patients aged 22 to 42 years, undergoing surgery at four centers, were randomly allocated to receive either the gel or no adhesion prevention. The incidence and severity of postoperative adhesions were assessed laparoscopically after 12 to 14 weeks in a blinded, scored fashion. A higher proportion of patients receiving the gel were free from adhesions compared with control patients. In subjects undergoing myomectomy without any concomitant surgery, though there was no significant difference in the proportion of adhesion free patients , a significant difference was found in the mean severity scores (Table 4 ). In subjects without uterine adhesions prior to myomectomy, a significant diffe rence was found in the severity of uterine adhesions.
Solution of HA (Sepracoat)
It was the study by Diamond 17 in 1998 which looked at patients who underwent gynecologic procedures by means of a prospective, randomized, blinded, placebocontrolled multicenter study. Surgeons assessed their adhesions during secondlook laparoscopy approximately 40 days later. The Sepracoat group had a significantly lower incidence of de novo adhesions than the placebo group as assessed by the proportion of sites involved and the percentage of patients without de novo adhesions as well as significantly reduced adhesion extent and severity (Table 5) .
Oxiplex
The study of 2005 by Young et al 18 was aimed at patients undergoing laparoscopic surgery with pelvic adhesions, tubal occlusion, endometriosis, and/or dermoids. They were randomized to receive Oxiplex or no further treatment after surgery. The mean baseline (American Fertility Society adhesion score) AFS score for each group was 8.0 (Table 6) . At second look, treated adnexa had the same score (8.1), whereas in control adnexa the score increased (8.011.6).
CONClUSION
The decision whether to use an adhesion barrier or not, need to be well thought out one. We need to weigh the balance between the efficacy of the material used against the cost implications involved. The reasonable conclusions that we were able to reach in the light of the available evidence are mentioned below.
Oxidized regenerated cellulose (Interceed) effectively helps to reduce the incidence and extent of postoperative adhesions, even in high risk groups (including patients with severe endometriosis). Though icodextrin (ADEPT) was found to be safe in laparoscopic surgery, no beneficial clinical effects could be established with its use. Autocross linked hyaluron gel appears to have a favorable safety profile as well as an efficacious antiadhesive action following lapa roscopic gynecological procedures with the available data. Sepracoat appears to be one of the most promising adhesive barriers, in not only being safe but also significantly reducing the incidence, extent and severity of de novo adhesions at multiple sites indirectly traumatized by gynecologic surgery. Oxiplex too appears to be an adhesion barrier for the future with its safety and efficacy being demonstrated, though larger study results are still being awaited.
